Tuberculosis: Latency and reactivation

Infection and Immunity

Volumn 69, Issue 7, 2001, Pages 4195-4201

  Flynn, J L ^a   Chan, J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST RESISTANCE; IMMUNE RESPONSE; INFECTION PREVENTION; LATENT PERIOD; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SHORT SURVEY; TUBERCULOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; TUBERCULOSIS;

EID: 0034977241     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.7.4195-4201.2001     Document Type: Short Survey

References (82)

1. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus
2. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
3. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent
4. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
5. Interaction of Mycobacterium tuberculosis with murine dendritic cells
6. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: Requirement for IFN-gamma and primed lymphocytes
7. Metronidazole therapy in mice infected with tuberculosis
8. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
9. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis
10. Latent and reactivation tuberculosis. Einstein Q.
11. Effect of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
12. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
13. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
14. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex
15. Disseminated tuberculosis in IFN-γ gene-disrupted mice
16. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
17. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
18. Pathogenesis of pulmonary tuberculosis: An interplay of tissue-damaging and macrophage-activating immune responses - Dual mechanisms that control bacillary, multiplication
19. Metronidazole has no antibacterial effect in Cornell model murine tuberculosis
20. A mutant strain of Mycobacterium tuberculosis with no oxygenated mycolic acids is attenuated in mice
21. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country
22. Immunology of tuberculosis
23. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection
24. Immune responses in tuberculosis
25. Tumor necrosis factor-α is required in the protective immune response against M. tuberculosis in mice
26. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
27. Effects of aminoguanidine on latent murine tuberculosis
28. A novel mycolic acid cyclopropane synthetase is required for cording, persistence and virulence of Mycobacterium tuberculosis
29. Sigma factors of Mycobacterium tuberculosis
30. sigA is an essential gene in Mycobacterium smegmatis
31. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis
32. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)
33. The challenge of tuberculosis in decline. A study based on the epidemiology of tuberculosis in Ontario, Canada
34. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta
35. Cross-modulation by transforming growth factor β in human tuberculosis: Suppression of antigen-driven blastogenesis and interferon γ production
36. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monoclytes by transforming growth factor-β1
37. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers
38. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis
39. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5)
40. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
41. Therapy of tuberculosis in mice by DNA vaccination
42. Identification of nitric oxide synthase as a protective locus against tuberculosis
43. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
44. Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase III trial
45. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor
46. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection
47. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli
48. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues
49. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug
50. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
51. Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis
52. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice
53. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
54. Effect of age on the enzymes of tricarboxylic acid and related cycles in Mycobacterium tuberculosis H37Rv
55. Mycobacterium tuberculosis inhibits MHC Class II antigen processing in murine bone marrow macrophages
56. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions
57. A mouse model of the recrudescence of latent tuberculosis in the elderly
58. Mouse model of tuberculosis
59. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria
60. Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA
61. Presentation of mycobacterial antigens by human dendritic cells: Lack of transfer from infected macrophages
62. Genetic advances for studying Mycobacterium tuberculosis pathogenicity
63. Granuloma-specific expression of Mycobacterium virulence proteins from the glycinerich PE-PGRS family
64. Lymphocyte subsets in granulomas of human tuberculosis: An in situ immunofluorescence study using monoclonal antibodies
65. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts
66. Persistence of tuberculous infection
67. TNF-α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages
68. Reactivation of latent tuberculosis: Variations on the Cornell murine model
69. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of IFN-γ, and NOS2
70. A prospective study of the risk of tuberculosis among intravenous drug users with human immuno-deficiency virus infection
71. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
72. Does the risk of tuberculosis increase in old age?
73. Recent advances in epidemiological research in tuberculosis
74. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1
75. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells
76. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions
77. Synchronized replication of Mycobacterium tuberculosis
78. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis
79. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions
80. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence
81. Attenuation of MHC Class II expression in macrophages infected with Mycobacterium bovis BCG involves class II transactivator and depends on the Nramp1 gene